Current Progress in CAR-T Cell Therapy for Solid Tumors

Cancer immunotherapy by chimeric antigen receptor-modified T (CAR-T) cells has shown exhilarative clinical efficacy for hematological malignancies. Recently two CAR-T cell based therapeutics, Kymriah (Tisagenlecleucel) and Yescarta (Axicabtagene ciloleucel) approved by US FDA (US Food and Drug Admin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Biol Sci
Autors principals: Ma, Shuo, Li, Xinchun, Wang, Xinyue, Cheng, Liang, Li, Zhong, Zhang, Changzheng, Ye, Zhenlong, Qian, Qijun
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2019
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6854376/
https://ncbi.nlm.nih.gov/pubmed/31754328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.34213
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars